Robert Kennedy Jr. Pushes New Healthcare Pricing Rules as HHS Says Patients Deserve Clearer Costs: ‘Americans Should Know…’
Key takeaways
- HHS’s new transparency rules tighten pricing data, shift reporting to quarterly, and add phone‑based cost disclosures, forcing insurers to overhaul reporting and potentially reshape plan offerings.
- Reporting frequency shifts from monthly to quarterly
- Prescription Drug File schema development starts November 2026
- Issuers expected to publish using the new schema December 2027
What happened
The U.S. Department of Health and Human Services finalized new rules to improve healthcare price transparency, tightening the existing Transparency in Coverage requirements. The regulations cut duplicate pricing data, add context to in‑network prices, broaden out‑of‑network pricing details, and require quarterly reporting instead of monthly. Group plans and insurers must also give consumers personalized cost‑sharing info by phone, not just online. The rules are part of a broader effort to let…
Why it matters
These changes aim to give patients clearer, more reliable cost information, helping them compare plans and make informed decisions. By reducing data duplication and increasing accuracy, the rules could lower surprise medical bills and improve trust in the insurance system. The shift to quarterly reporting may reduce…
Short-term and longer-term
Short-term. In the short term, insurers may see modest price swings as they adjust to the new reporting cadence—Cigna and UnitedHealth dipped slightly after the announcement.
Longer-term. Over the next few months, the transparency rules could prompt insurers to revise their pricing models and potentially raise premiums to cover compliance costs.